Chronic systemic thrombosis of unknown etiology with concurrent essential thrombocythemia and recurrent stroke: A case report
Here, we report a male patient under hypercoagulable state of unproven etiology, who used to present with recurrent thrombotic episodes since young age after he stopped taking anticoagulant. At the age of 73, he was detected to have essential thrombocythemia while grappling with recurrent strokes. On both occasions, he presented with a basilar thrombus. His National Institutes of Health Stroke Scale (NIHSS) score improved from 18 to 2 on the first occasion and from 17 to 2 sixteen days later on the second occasion. Thrombolysis was done on both occasions, but endovascular therapy was not done on either occasion due to chronicity of the thrombus and remarkably improved NIHSS post-thrombolysis. For patients with recurrent thrombotic events of undetermined etiology, an anticoagulant should be indicated. Repeat thrombolysis can be performed without endovascular therapy within a brief gap of 16 days, even in stroke patients with moderate to high NIHSS.
- Fauchier L, Bisson A, Bodin A, et al. Ischemic stroke in patients with hypertrophic cardiomyopathy according to presence or absence of atrial fibrillation. Stroke. 2022;53(2):497-504. doi: 10.1161/STROKEAHA.121.034213
- Pavaloiu RM, Mogoanta L. Repeated events of acute ischemic stroke in a patient with essential thrombocythemia. Curr Health Sci J. 2017;43(1):95-97. doi: 10.12865/CHSJ.43.01.16
- Cervantes F. Management of essential thrombocythemia. Hematology Am Soc Hematol Educ Program. 2011;2011:215-221. doi: 10.1182/asheducation-2011.1.215
- Kahles T, Mono ML, Heldner MR, et al. Repeated intravenous thrombolysis for early recurrent stroke: Challenging the exclusion criterion. Stroke. 2016;47(8):2133-2135. doi: 10.1161/STROKEAHA.116.013599
- Singh RJ, Chakraborty D, Dey S, et al. Intraluminal thrombi in the cervico-cephalic arteries. Stroke. 2019;50(2):357-364. doi: 10.1161/STROKEAHA.118.023015
- Patel K, Mikhael E, Liu M, et al. Anticoagulation therapy reduces recurrent stroke in embolic stroke of undetermined source patients with elevated coagulation markers or severe left atrial enlargement. Front Neurol. 2021;12:695378. doi: 10.3389/fneur.2021.695378
- Hasan MS, Basri HB, Hin LP, Stanslas J. Genetic polymorphisms and drug interactions leading to clopidogrel resistance: Why the Asian population requires special attention. Int J Neurosci. 2013;123(3):143-154. doi: 10.3109/00207454.2012.744308